• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>BMC Medical Informatics and Decision Making >Impact of an interactive web tool on patients’ intention to receive COVID-19 vaccination: a before-and-after impact study among patients with chronic conditions in France
【24h】

Impact of an interactive web tool on patients’ intention to receive COVID-19 vaccination: a before-and-after impact study among patients with chronic conditions in France

机译：交互式网络工具对患者接受Covid-19疫苗接种的意图的影响：法国慢性疾病患者的患者前后影响研究

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In France, about 30% of the population refuses COVID-19 vaccination outright, and 9 to 40% are hesitant. We developed and evaluated an interactive web tool providing transparent and reliable information on the benefits and risks of COVID-19 vaccination. The most recent scientific data at the time of the study were implemented into an interactive web tool offering individualized information on the risks of COVID-19 infection-related events versus vaccination-related serious adverse events. The tool was evaluated during a before-and-after impact study nested in ComPaRe, a French e-cohort of adult patients with chronic conditions. Primary outcome was the proportion of patients intending to receive vaccination after using the tool, among those not intending to receive it at baseline. Between January 8 and 14, 2021, we enrolled 3152 patients in the study [mean age 55.2 (SD: 16.9), 52.9% women and 63% with ≥?2 chronic conditions]. Before consulting the tool, 961 (30.5%) refused to be vaccinated until further data on efficacy/safety was obtained and 239 (7.5%) outright refused vaccination. Among these 1200 patients, 96 (8.0%, number needed to treat: 12.5) changed their mind after consulting the tool and would subsequently accept vaccination. Our interactive web tool represents a scalable method to help increase the intent to receive COVID-19 vaccination among patients with chronic conditions and address vaccine hesitancy. Since April 2021, our tool has been embedded on the official webpage of the French Government for COVID-19 information.
机译：在法国，大约30％的人口拒绝了Covid-19疫苗，而9至40％犹豫不决。我们开发并评估了一个互动网络工具，提供有关Covid-19疫苗接种的益处和风险的透明和可靠的信息。研究时最近的科学数据是在交互式网络工具中实施，提供有关Covid-19相关事件的风险与接种相关的严重不良事件的个性化信息。该工具在嵌套在比较的患者中嵌套的患者的前后研究工具，是一名慢性病症的法国电子患者。主要结果是在使用该工具后打算接种接种疫苗的患者的比例，其中不打算在基线接受它。在8月8日和14日，2021年1月8日之间，我们注册了3152名患者[平均55.2（SD：16.9），52.9％妇女和63％，≥2慢性条件]。在咨询工具之前，961（30.5％）拒绝接种疫苗，直至获得有关疗效/安全的进一步数据，239（7.5％）完全拒绝疫苗接种。在这1200名患者中，96名（治疗需要8.0％：12.5）在咨询工具后改变主意，随后会接受疫苗接种。我们的交互式网络工具代表了一种可扩展的方法，以帮助增加慢性条件患者接受Covid-19疫苗接种的意图和地址疫苗犹豫不决。自2021年4月以来，我们的工具已嵌入法国政府的官方网页，用于Covid-19信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号